Clinical Research and CROs in 2024: Insights from Scott Schliebner
Release Date:
Clinical research is a vital part of developing new treatments and cures for diseases. But it is also a complex and challenging process that faces many obstacles and inefficiencies.
Scott Schliebner is a Clinical Development Executive and advisor to early-stage biotech companies, helping them to design and execute clinical trials.
In the latest episode of the PharmaSource podcast, he shares his insights on some of the current problems and opportunities in clinical research, and how biopharmas can navigate the complex CRO industry in 2024.
Read the full interview here
Clinical Research and CROs in 2024: Insights from Scott Schliebner